This site is intended for healthcare professionals only

HPV jab found safe and effective by a systematic review

Written by: | Published:

The Gardasil jab protects women against strains 16, 18, 6, and 11 of HPV – 16 and 18 have the highest risk of developing into cancer

The human papillomavirus (HPV) vaccine, which is offered to young women across the UK, has been found to be safe and effective against the cancer causing virus.

A systematic review by the Cochrane Group looked at 26 trials which involved 73,000 participants and found that the vaccine is protective.

‘This study adds to the wealth of growing evidence from around the world which shows that the HPV vaccine is the most effective way for young girls to protect themselves against cervical cancer,’ said Mary Ramsay, head of immunisations at Public Health England (PHE).

The NHS offers the vaccine free for young women between 12 and 18 years old. It protects them against strands of the human papilloma virus which can cause changes to cells in the cervix that can lead to cervical cancer.

The Gardasil jab protects women against strains 16, 18, 6, and 11 of HPV – 16 and 18 have the highest risk of developing into cancer.

HPV is a very common infection and spread by skin-to-skin contact, usually during sex. Most people who are infected are symptomless and usually the virus clears up on its own, but when it stays in the system, it can cause cancer.

‘Cervical cancer is one of the few cancers that can be largely prevented through the fantastic cervical screening and HPV vaccination programmes we are fortunate to have, this review clearly demonstrates the role of the vaccine in reducing precancerous cells,’ said Robert Music, chief executive of Jo’s Cervical Cancer Trust, which supports women with cervical cancer.

Mr Music also echoed many health professionals’ calls to extend the vaccine to boys as well. He argued this is necessary both because boys can spread HPV, and the virus can develop into other cancers which will affect them, such as throat, anal and penile cancer.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Comments

Name
 
Email
 
Comments
 

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code
 

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.